BillionaireNet
family
Liu Gexin & family
Rank #2316
CHINAHealthcarePharmaceuticals

Liu Gexin & family

Net Worth
$1.611B
-0.38% (24h)
Liu Gexin, the 74-year-old chairman of Sichuan Kelun Pharmaceutical, has built a significant fortune in the healthcare industry. His net worth is estimated at $1.8 billion, stemming from his leadership of Kelun Pharmaceutical, a prominent maker of antibiotics and traditional Chinese medicine. Liu established Kelun Pharmaceutical Factory in 1996, which later became Sichuan Kelun Pharmaceutical, and took the company public on the Shenzhen Stock Exchange in 2010. Liu's career has been marked by achievements in the pharmaceutical sector, making him a leading figure in the industry.

The Full Dossier

Early Life

Information on Liu Gexin's early life is limited. However, it is known that he was born in 1951.

Rise to Success

Liu Gexin established Kelun Pharmaceutical Factory in 1996, serving as its chairman. He spearheaded the company's growth, and Kelun was listed on the Shenzhen Stock Exchange in 2010. Under his leadership, Kelun has become a major player in the pharmaceutical industry.

Key Business Strategies

Liu Gexin's strategic focus on the production of antibiotics and traditional Chinese medicine has been key to Kelun's success. The company's focus on research and development, along with expansion of its product lines and sales networks, has driven revenue growth. Kelun's diversification into other market segments has also contributed to its financial performance.

Philanthropy

The search results do not provide specific details on Liu Gexin's philanthropic activities.

Career Timeline

2017

Top 10 Commercial Leaders

Awarded as one of the Top 10 Commercial Leaders in China's Pharmaceutical Industry in 2017.

2010

Kelun went public

Kelun Pharmaceutical was listed on the Shenzhen Stock Exchange.

1996

Founded Kelun Pharmaceutical Factory

Established the predecessor company of Sichuan Kelun Pharmaceutical.

Philanthropic Impact

Unspecified$0B

Not available

Information on specific philanthropic initiatives is not available.

Wealth Trajectory